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Differentiation of Cultured Epithelial Cells:
Response to Toxic Agents
by Robert H. Rice,* Anthony D. LaMontagne,*
Catherine T. Petito,* and Xianhui Rong*
Cell culture systems are instrumental in elucidating regulation ofnormal function and mechanisms ofits
perturbation by toxic substances. To this end, three applications ofepithelial cells cultured with 3T3 feeder
layersupport are described. First, treatmentofthepremalignant human epidermal keratinocyte line SCC-12F2
with the tumor promoter 12-O-tetradecanoylphorbol-13-acetate suppressed cell growth and differentiation.
This agentproduced abiphasic growth response greatly inhibiting cell growth at 1 to 10 nM, but much less
above 100 nM. Expression ofthe differentiated functions involucrin and transglutaminase was found to be
inhibited markedly at concentrations above 10 nM. Second, 3-methylcholanthrene toxicity was surveyed in
avariety ofrat epithelial cell types. The two most sensitive to growth inhibition were epidermal and mam-
maryepithelial cells, while those from bladder, prostate, thyroid, andendometrium were insensitive to growth
inhibition. Great differences were evident even amongthose cells derived from stratified squamous epithe-
lia (epidermal, esophageal, vaginal, forestomach) despite their expression ofaryl hydrocarbon hydroxylase
activities to similar degrees. Finally, expression ofestrogen receptors in rat endometrial cells was shown to
be stimulated by the cAMP-elevating agent forskolin. Maximal stimulation of3- to 6-fold occurred in 6 hr,
compatible with a requirement for protein synthesis. Although expressing keratinocyte character (trans-
glutaminase activity andenvelope formingability), the cells thus retain some hormonal characterthat may
be modulated by cAMP-dependent kinase activity. Pursuit ofsuch results will aid in understanding differ-
ences in response amongcell types andspecies, in elucidating mechanisms ofaction ofknown toxic substances
and, ultimately, in predicting toxicity ofless well understood agents.
Introduction
Despite the variety of toxicity testing methods now
available, vexing uncertainties persist in estimating the
risk to humans posed by environmental contaminants.
Majorproblems arise in extrapolatingtest results among
species, fromhigh to lowdoses, and to chemical mixtures.
Advances in dealing with these uncertainties are antici-
patedto resultfrombettermechanisticunderstanding of
the interactions of agents with target cells. In turn, as
differentiated functions oftarget cells become better un-
derstood, the actions oftoxic agents willbe more readily
elucidated. An added incentive to examining the pertur-
bation ofcellular processes is that such study is likely to
provide further insight into normal regulatory and de-
velopmental phenomena, some ofwhich are poorly under-
stood at present.
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Inasmuch as they are common targets ofenvironmen-
tal agents, keratinocytes are especially appropriate for
this type ofinvestigation. Considerable information has
accumulated on the differentiated functions of this cell
type (1), which can now be serially cultivated from hu-
mans andvarious animal species. Amongthe useful mar-
kers of keratinocyte maturation available for study (in-
cluding filaggrin and the keratin intermediate filament
proteins) are involucrin and keratinocyte trans-
glutaminase. The latter is a membrane-bound enzyme
responsible for cross-linking involucrin (2,3) and certain
otherproteins(4,5)intoinsoluble cornifiedenvelope struc-
tures (6,7). Involucrin is found throughout the primate
order(8)buthasbeendifficult toidentifyinotheraniimals,
although evidence has been reported recently for a
related protein in bovine epidermis (9). Keratinocyte
transglutaminase is distinct from the tissue trans-
glutaminasefoundinmanycelltypesinitsregulationand
itsbiochemical andimmunochemicalproperties(7,10,11).
The relationships ofthese enzymes to the soluble trans-
glutaminasespurifiedfrom epidermis and hairfollicle are
uncertain (12-14).RICE ETAL.
One approach to investigating toxicmechanisms in cul-
ture hasbeento examine directlythe neoplastic response
of keratinocytes to tumor initiators, promoters, and on-
cogenes (15), in some cases treating the animal skin be-
fore cultivation (16). This work often exploits the sensi-
tivity ofnormal but nottransformed murine cells to high
calcium medium, where they terrninally differentiate (17).
Both normal andmalignant humankeratinocytes express
xenobiotic metabolism (e.g., aryl hydrocarbon hydroxy-
lase) in culture and consequently are sensitive to DNA
damage and the mutagenic action ofpolycyclic aromatic
hydrocarbons and related agents. Applicability ofthese
cells to investigating mechanisms ofmutagenesis and to
screening ofunknowns for mutagenic potency has been
described (18).
A second approach to studying toxic mechanisms has
been to examine the physiological modulation ofkeratino-
cyte differentiation and its disturbance bymodel agents.
Acquisition ofmalignancy isgenerallyamultistepprocess
that canbe set in motion bygenetic damage, although al-
teration ofdevelopmental or otherprocesses not clearly
involving DNA damage can be important (19). Rare
genetic events often appeartoberatelimiting, butrecent
evidence points to a role for common cellular events in
carcinogen-treated populations in enhancingtheincidence
or detection ofmalignant change (20,21). Moreover, the
desirabilityoftestingforchronictoxicityotherthan car-
cinogenesis isevident. Interference ofmodelagentsinthe
regulation of cellular processes or responses to signals
fromtheirmicroenvironment maybe diagnosticforava-
riety of syndromes, possibly even at target sites other
than stratified squamous epithelia.
For example, in view of their responsiveness to
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (22), as well as
to a number of endogenous effectors of differentiation,
keratinocytes (includingcelllines derivedfromneoplasias)
provide auseful modelinwhich to studytheactionofthis
agent. Pursuant to previous indications that the toxic ac-
tion ofTCDD may result from its interference with nor-
mal hormone action (23), a number of studies have now
reportedexamples ofthisphenomenon (24). Malignant hu-
man keratinocytes appear defective in their ability to
differentiate terminally(25). However, they can exhibit at
confluence amoderately high level ofkeratinocyte trans-
glutaminase, which is expressed in normal epidermis in
the upper spinous layer (7), and a high keratin content.
Hydrocortisone in the culture medium stimulates these
markers 4- to 6-foldinthe SCC-13cellline. TCDD haslit-
tle effect on their expression in the absence of added
glucocorticoid, but it largely antagonizes the action of
hydrocortisone whenthe cells are grown in the presence
ofboth agents (26).
In contrast to SCC-13, the SCC-4 cell line shows rela-
tivelylittle keratinocyte characterbut does exhibitgreat
sensitivity to vitamin Ain induction oftissuetransgluta-
minase tohighlevels(11). TCDD inthemediumprevents
the induction by retinoic acid orretinyl acetate. The con-
centration dependence ofthis action(EC50 = 20pM) was
virtually identical to that for induction of aryl hydro-
carbonhydroxylase, compatible withmediationbytheAh
receptor. The loss ofcell sensitivity to vitaminAwas also
observed with 3-methylcholanthrene andbenzo[a]pyrene
butnotpyrene or dibenzofuran. If, asgenerally assumed,
the tumorpromoting activity ofTCDD is receptormedi-
ated, this result suggests the promoting activity ofcar-
cinogenic polycyclic aromatic hydrocarbons may be at
least in part conferred in the same way, independent of
the generation of DNA-damaging electrophiles (24).
Materials and Methods
Cell Culture
SCC-12F2 keratinocytes were grown with 3T3 feeder
layer support (27) in a 3:1 mixture ofDulbecco-Vogt Ea-
gle's and Ham's F-12 media supplemented with fetal bo-
vine serum(5%), hydrocortisone (0.4,g/mL), transferrin
(5 ,ug/mL), insulin (5 ,ug/mL), adenine (0.18 mM), triiodo-
thyronine(20pM), andantibiotics. Themediumforthe rat
epithelial cells (28,29) also contained epidermal growth
factor and cholera toxin (each approximately 10 ng/mL).
The medium was changed at 3 to 4 day intervals. In
experiments employing TPA or 3-MC (both from Sigma
ChemicalCo., St. Louis, MO), the agentwas dissolved in
dimethylsulfoxide and diluted from a stock solution into
medium togive afinal solvent concentrationof0.1%. Cul-
tures were treated starting 1 to 2 days after inoculation
and at each medium change with the indicated agent or
solvent (control) and after approximately 2 weeks were
fixed and stained withrhodanile blue (30). Rat epithelial
cells were usedfortoxicity studiesinpassages 3 to 4(ap-
proximately 30 to 40 generations).
Assays
SCC-12F2cellswererinsedwithisotonic saline, scraped
into tubes with buffer (10 mM Tris-Cl, pH 7.5, 1 mM
EDTA, 1% Emulgen911)andstoredfrozen. Thawed sam-
ples were disrupted by sonication and centrifuged at
100,OOOg for 45 min. Ib measure involucrin content, ali-
quots ofthe supernatantofappropriate dilution were in-
cubated overnightwith0.06mL ofrabbit anti-involucrin
antiserum (2), diluted 1:1500, transferred to a 96-well
plate containing adsorbed, partially purified involucrin,
incubated 30 min, and washed. Antibodies remaining
bound to the wells were quantitated by treatment with
proteinA-alkalinephosphatase conjugate andsubsequent
incubation with p-nitrophenylphosphate. Absorbance
values at 405 nm were measured using a Tltertek Mul-
tiskan, and involucrin values were calculated from stan-
dard curves generated in parallel with samples of chro-
matographicallypurified involucrin(8). Fromthe original
crude sonicates, aliquots were assayed for trans-
glutaminase infinalvolumes of0.26 mLcontaining0.5mg
of dimethylcasein, 100 mM Tris-HCl (pH 8.2), 4 mM
CaCl2, 0.4 mM EDTA, 5 mM dithioerythritol, 15 mM
putrescine, and 0.5,Ci of3H-putrescine. After30 minin-
cubation at 370C, protein-bound radioactivity was reco-
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vered by trichloroacetic acid precipitation on glass fiber
filters, rinsed with trichloroacetic acid and ethanol, and
measured by scintillation counting (11). Measures of in-
volucrin andtransglutaminasewerenormalizedtoprotein
content of the sonicate assayed with bicinchoninic acid
(31).
For assay of estrogen receptors$ rat endometrial cells
(passages 10-15) were treated withforskolin (dissolved in
ethanol; final solvent concentration 0.05%) just as they
reached confluence. After appropriate incubation, the cul-
tures were rinsed in isotonic saline, scraped into tubes,
and sonicated inbuffer(10 mM Tris-HCl, pH 7.4, 20 mM
NaMoO4, 2mM dithioerythritol). Samples were then ad-
justedto 0.4 M in KCl, stirredfor20minatOOC, and cen-
trifuged for45 min at 100,000g. Aliquots ofthe superna-
tant were adjusted to 1 nM in 3H-estradiol (tv 100
Ci/mmole; NewEngland Nuclear, Boston, MA) ± 200 nM
unlabeled estradiol, incubated for 1 hr at 300C, and the
bound ligand recovered by hydroxyapatite precipitation
and subsequent ethanol elution (32). Several other es-
tradiol concentrations were employedinoccasionalexperi-
ments and gave essentially the same results. Specific
binding was normalized toprotein content in the soluble
extract (typically 1 mg/mL) as measured by Coomassie
G-250 dye binding (33).
Results
12-O-Tetradecanoylphorbol-13-Acetate
Celllines derivedfromepidermal squamouscarcinomas
aregenerally insensitive to the toxic effects of12-0-tetra-
decanoylphorbol-13-acetate (TPA) compared to normal
epidermal cells(34,35), as shownforSCC-13 in Figure 1.
Aspecial caseisthehumanepidermalline SCC-12F2, im-
SCC-13_
SCC-12F2:. ~ 1l
TA (nM) 0.01
mortalbutnotmalignant(27), whichis reduced in colony-
forming efficiency bythis agent(34). Asillustrated in Fig-
ure 1, TPA produces anoticeable reduction in growth at
0.16 nM and largely prevents colony expansion at 1.6 to
16 nM. At the highest concentration tested, 160 nM, the
growthratewashigherthanat 1.6to 16nM. Closeinspec-
tion through the culture microscope indicated that slow
cell growth was continuing at the latter concentrations,
but discrete colonies were not easily distinguishable by
staining, probably due atleastinpart to the altered mor-
phology ofthe cells and loss of their usual close associ-
ation with each other. At higherinoculation densities, the
treated cultures reached confluence and could be main-
tained for several weeks.
Asfoundwith otherneoplastic keratinocyte lines such
as SCC-13 (36), SCC-12F2 cells showed little differen-
tiated characterduringlog-phasegrowthwith3T3feeder
layer support. However, keratinocyte properties became
evident as the cultures reached confluence, as shown in
Figure 2. Transglutaminase activity rose from very low
to appreciable values as the cells approached confluence,
reaching approximately 10-foldhigherlevelsthan during
mid-log-phase growth. Involucrin content increased
50-foldormorefrombasallevels, butthisriseconsistently
occurred several days later than that of the transglu-
taminase. The ability of the cells to make cross-linked
envelope structures upon stimulation by the ionophore
X537Aincreased largely in concertwithmeasured activ-
ity ofthe cross-linking enzyme. Atearly times, however,
it was evident that the enzyme alone is insufficient to
form the structures(evidently, substrates arelacking). In-
corporation ofinvolucrin likely stabilizes the structures,
butis notrequiredfortheirinitialformationunderthese
artificial conditions. Competence levels remainedhigh as
the cells were maintained at confluence, indicating that
1*6 16 160
FIGURE 1. Effect of 12-0-tetradecanoylphorbol-13-acetate (TPA) on growth of SCC-12F2 and SCC-13 cells.
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FIGURE 2. Kinetics of expression of transglutaminase, involucrin, and
envelope competence in SCC-12F2 cells. Cultures inoculated with 105
cells/dish were harvested atthe timesindicated and assayed. Values
shown are the mean and range ofdeterminations in duplicate cultures.
The rangeofenvelope competencemeasurements, performed asprevi-
ously described(36), was ±6%. The culturesbecame confluent on day
10 (1). In other experiments, transglutaminase activity measured
several days earlierthanthe firsttimepoint shown wasapproximately
10% ofthe maximum value attained shortly after confluence.
necessary components were present in sufficient amounts
despite the slow decline detected in both transglu-
taminase and involucrin. Similar observations have been
made using SCC-9 cells, in which involucrin accumulation
follows the rise in transglutaminase by at least a week
(37). Measures ofionophore-stimulated envelope-forming
ability evidently reflect aproperty ofthe cells for which
a correspondence to certain transglutaminase substrates
is not yet established, and which may even vary with the
physiological state ofthe cells (38,39). Thus, the present
work has concentrated specifically on expression of the
known markers transglutaminase and involucrin.
Cultures treated chronically with TPA were examined
fortheir expression ofthese keratinocyte differentiation
markers, as shown in Figure 3. The cells were harvested
5 to 6 days after confluence, when the markers in paral-
lel control cultures were at maximal values. Measure-
ments made 2 to 3 weeks after confluence gave similar
results, although the control values were considerably
lower, as indicated in Figure 2. Cultures treated with
1 nM TPA showed a small elevation in the specific activ-
ityofboth markers, while thosetreatedwithhigher con-
centrations showed substantial reductions. Theinvolucrin
content, more sensitive than transglutaminase activity,
was reduced toless than 10% ofthe controlvalue at 1 AM
TPA.
Polycyclic Aromatic Hydrocarbon ¶bxicity
Epithelial cells from a variety ofrat tissues are cultiv-
able with 3T3 feeder layer support (28,29). A survey of
their sensitivities to inhibition of growth by 3-methyl-
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FIGURE 3. Effect ofTPA on transglutaminase and involucrin expression
in SCC-12F2 cells. Cultures grown as in Fig. 2were treatedwiththe
indicated concentration ofTPA and harvested 3 days afterconfluence
for assay of transglutaminase (0) and involucrin (0).
cholanthrene (3-MC) has shown striking differences, as
summarized in Table 1. This agent produced its most
powerful effect inrat epidermal andmammary epithelial
cells, with aconcentration dependence similarto thatob-
servedpreviously forepidermal cells (40), whereas blad-
der, prostate, thyroid, andendometrialcells, forexample,
were insensitive. Thebasisforthis difference inresponse
remains to be elucidated. That the sensitive cells
responded only to a small extent to TCDD compared to
3-MC in the medium, as shown in Figure4, indicates that
the production ofmetabolites wasimportant andnot sim-
plyactivation ofwhatevergenes areunderthe control of
the Ah receptor.
The actionofneitherTCDD nor3-MC onthe epidermal
cellswas alteredby omission ofepidermalgrowthfactor
from the medium (S. E. Crane and R. H. Rice, unpub-
lished), indicating that inhibition ofgrowth could not be
ascribed primarily to the loss ofreceptors for this poly-
peptide that occurs in humanepidermal andcertainkera-
tinocyte lines (41,42). Although rat epidermal cells are
highly sensitive to 3-MC in earlypassage, we have previ-
ouslyfoundthatupon continued propagationboth sensi-
tivity andexpression ofarylhydrocarbon hydroxylase ac-
tivity are lost, suggestingthe latteris necessaryfor the
evidenttoxicity. However, similartopreviousfindings,the
capacities tometabolizepolycyclicaromatichydrocarbons
were comparable in the cell types examined (epidermal,
esophageal, forestomach, vaginal, mammary). Suchmeas-
urements in growing or confluent cultures have not dis-
tinguished sensitive and insensitive cell types, implicat-
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FIGURE 4. Sensitivity ofrat mammary epithelial cells
ingotherfactors as well in determining the response (40,
S. E. Craneand R. H. Rice,unpublished data). The actual
metabolites have notbeenanalyzed, leavingopen the pos-
sibility of critical differences in hydroxylation, conjuga-
tion, DNArepair, quinone orradical scavenging, or even
cooxidation with arachidonic acid upon membrane dam-
age. In regard to the latterpossibility, growth ofthe rat
mammary cells inthepresence ofcyclooxygenase orlipo-
xygenase inhibitorsindomethacin or BW755C(up to 3JAM
or 1 MM, respectively, above which the agents were toxic
alone) did not reduce the toxicity of 0.2 to 2 MM
benzo[a]pyrene in the growth medium. Moreover, addi-
tionof1 MM arachidonic acid tothemedium didnotinhibit
the cellgrowthalone orinthepresence ofbenzo[a]pyrene
(E. Choi and R. H. Rice, unpublished).
Estrogen Receptor Modulation
Rat endometrial cellsgrownwith feederlayersupport
express estrogen receptors at a modest level (32), a sta-
ble characteristic even after approximately 200 genera-
tions. Additives to the culture medium such as hydro-
Table 1. Inhibition ofcolony expansion.
Inhibitory activitya
Epithelial origin TCDD 3-MC
Epidermal + +++
Mammary + +++
Seminal vesicle + ++
Forestomach + + +
Pituitary + +
Esophageal - -
Vaginal
Prostate - -
Thryoid - -
Bladder b
Endometrial b
'The degree of colony growth inhibition in the presence of TCDD
(10mM) or3-MC (4pM)wasjudged incomparison withparallel solvent-
treated controls as none (-) or mild (+) to severe (++).
bNot tested.
tDD growth .... by ... 3nMaM C (2 MM).
,to growth inhibition by TCDD (10 nM) and 3-MG (2 ,uM).
cortisone and epidermal growth factor had little or no
observable effect onreceptor content. However, agents in-
creasing production of cAMP (cholera toxin, forskolin)
were found to raise substantially the receptorlevel with-
out significant effect onaffinityfortheligand. As shown
in Figure 5, forskolin at high concentration (100 MM) in-
creased the receptorlevelby 3- to 6-fold with an EC50 of
approximately 3 MM (left panel). Forskolin has also been
reported to increaseglucocorticoid receptorlevels2-fold
in murine lymphomacellswithoutalteringaffinityforthe
ligand (43). Steroid receptors are known to be subject to
phosphorylation, which modulates their ability to bind
ligand and may altertheiraffmityfor DNA acceptor sites
(44). The estrogenreceptoris asubstrateforacalmodulin-
dependent kinase thatphosphorylates acriticaltyrosine
residue (45). The presentfindingsindicate forskolin addi-
tion does not increase receptor number simply by
stimulatingcAMP-dependent receptorphosphorylation.
Its action takes approximately 6 hr for maximal effect
(Figure 5, right panel) and ispreventedby cycloheximide,
indicative of a requirement for protein synthesis (32).
Physiological agentsraisingintracellular cAMP, includ-
ingfollicle-stimulating hormone andprostaglandins E1 or
E2, are known to be effective in modulating functions of
estrogenresponsive cells ofthe femalegenital tract(46).
In a search for endogenous effectors that might be of
physiological relevance, culturesweretreatedwith crude
preparations ofseveral peptide hormones obtained from
the National Hormone and Pituitary Program. Standard
preparations ofovine (follicle stimulating hormone), por-
cine (follicle stimulating hormone, leutinizing hormone),
and rat(growthhormone, prolactin, hypothalamic extract)
origin employed undervarious conditions did notmateri-
ally alterthe receptorlevel. In some experiments, treat-
ment ofthe cultures withprostaglandins E1 or E2 led to
a2- to3-foldincrease inreceptorlevel overa4to 6hrtime
period (prostaglandins B1, '2 andF2Z were virtually inac-
tive), but this finding was not readily reproducible, per-
haps due to variable endogenous prostaglandin produc-
tion by the epithelial or the few remaining 3T3 cells.
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FIGURE 5. Estrogen receptor stimulation by forskolin. Rat endometrial cells were treated with forskolin at the indicated concentrations for 18 hr
(left panel) or at 100 ,pM for the indicated times (right panel). The cultures were then harvested and assayed for receptor content.
Discussion
Treatment ofculturedkeratinocytes fromnormal mouse
orhuman epidermis with TPAinduces a state resembling
terminal differentiation in amajority ofthe cells, although
a substantial fraction oftransiently resistant cells is evi-
dent corresponding to the germinative population
(34,35,41). This finding has suggested that sensitivity to
TPArequires some differentiated functionlacking inbasal
cells and certain human squamous carcinoma lines. How-
ever, such carcinoma cells can express considerable
differentiated function upon reaching confluence (36), sug-
gesting they might show a sensitivity to TPA under op-
timal circumstances. Growth of the malignant cell line
SCC-9 with 1 nM to 1IAM TPA in the mediumgave no hint
oftoxicity or stimulation of differentiation. Nevertheless,
expression ofinvolucrin andparticulate transglutaminase
in confluent cultures was greatly suppressed (37). In the
present experiments, it is clear that the latterphenome-
non occurs in SCC-12F2, a premalignant line in which
TPA does inhibit cellgrowth. Whether atransient stimu-
lation ofexpression ofthe two markers occurs after ini-
tial TPA treatment has not yet been established.
Upon chronic treatment ofSCC-12F2 (and SCC-9) cul-
tures, the TPA concentration dependence shows that
involucrin is considerably more sensitive to suppression
than transglutaminase. Whether this phenomenon repre-
sents an effect on transcription remains to be seen. The
keratinocyte transglutaminase is subject to phosphory-
lation, which is stimulable 5-fold by treatment of cul-
tured normal epidermal cells for several hours with TPA
(R. Chakravarty and R. H. Rice, unpublished). Thus, post-
translational modification(s) could account for some alter-
ation in measured activity. Moreover, involucrin is quite
sensitive toproteolytic degradation and could be subject
to rapid depletion as a consequence ofprotease activation.
Indeed, protein kinase C is dramatically depleted in a va-
riety ofcell types, including A431 malignant human ker-
atinocytes (48), as well as in mouse skin(49), perhaps due
to enhanced proteolysis (50). The possibility that TPA-
mediated production of reactive oxygen species (51,52)
may contribute to this differentiation suppression has not
been ruled out, however. If protein kinase C ordinarily
mediates keratinocyte differentiation, suggestedby its ob-
served stimulation ofdifferentiated properties in cultured
normal keratinocytes, then its depletion could be respon-
sible for the suppressive effect in these chronically
treated cells. Regardless of this hypothesis, a biphasic
growth inhibition response induced by TPA as in
SCC-12F2 has been reported in a number of cell types
(53). In some cases (such as this), perhaps a drastic deple-
tion ofprotein kinase C at the highest concentrations of
TPA employed could release the cells from a growth in-
hibitory influence ofthe kinase activity present at lower
concentrations.
Although keratinocytes from various anatomic sites
have much in common, they retain and under appropri-
ate circumstances display intrinsic differences in their
differentiation program(54), perhaps arisingin part as a
consequence oftheir developmental pathways. In addition
to pharmacokinetic factors, these differences are likely to
result in distinctive responses to physiological and patho-
logical conditions. The striking contrast in the response
ofcultured rat epithelial cells to the polycyclic aromatic
hydrocarbon 3-MC suggests these intrinsic differences
could have major influences on carcinogen target speci-
ficity, for example. It is not clear at present how relative
toxicity (growth inhibition) may relate to carcinogenicity
in this instance. One possibility, similar to the selection
scheme proposedforpreneoplasticlesions ofthe rat liver
(55), is that epidermal cells metabolizing the agent are
prevented from growing. Those variants arising which
lack such metabolic capability may then be selectively
provided with the opportunity to replace the normal cells.
Variants lacking aryl hydrocarbon hydroxylase that are
not sensitive to 3-MC toxicity do arise in epidermal cell
populations evenwithout 3-MC treatment upon continued
passage (28). Alternately, one could imagine that con-
tinued carcinogen metabolism by the esophageal cells
without toxicity might permit a greater burden of DNA
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damage to accumulate, thereby enhancing the rate of
progressiontomalignancy. Furtherinfornation onthe de-
gree ofDNA damage suffered by these cells and the ef-
fect of treatment on their growth properties may help
choose among such possible scenarios. Insensitivity to
3-MC and B[a]P but not to dimethylbenzanthracene, a
more potent carcinogen at this target site in vivo, has
been notedpreviously inprimary cultures ofrattracheal
epithelial cells (56). These cells express in surface culture
the metabolic capabilities observed in organ culture(5?).
While rodent epidermis and mammary epithelium are
well-known target sites for polycyclic aromatic hydro-
carbon carcinogenesis, few studies have examined syste-
matically the relativetarget sensitivity ofthese and other
sites. Ifthe observed sensitivity in culture reflects that
in the animal, examination ofitsbiochemical basismaybe
ofutility in improving extrapolation amongepithelia and
perhaps species.
'Ib what degree differentiatedproperties ofthe cultured
rat cells correspond to the epithelia oforigin remains to
be exploredin detail. Those derivedfrom stratified squa-
mous epithelia presumably retain the most normal func-
tion, althoughprobablyresemblingthehyperproliferative
state observed in human epidermal cells (58). With re-
spectto other celltypes, the adoption offeatures such as
high keratin content andenvelope-forming ability(29) and
expression ofaparticulate transglutaminase (14)indicate
a reprogramming resembling, but notnecessarily identi-
cal to (59), squamous metaplasia. In any case, the culture
phenotype appears to approximate behavior within the
cellularrepertoire invivo underconditions ofstress (hor-
monal imbalance, vitamin deprivation, physical trauma,
neoplastic influence). Squamous metaplasia is inducible
even in the rodent mammary epithelium(60) and is seen
inhuman mammarytissue(61). Newbiochemicalproper-
ties may well influence the target susceptibility ofthese
cells to exogenous agents or alter the ensuingpathology.
Loss of characteristic specialized function may be only
partial, withenoughremainingtopermit studyofimpor-
tantnormalprocesses. Thus, theresponsiveness ofestro-
genreceptor contentinthe ratendometrial cellstoagents
elevatingintracellular cAMP suggestspossible usefulness
in studyingthe mechanism ofthisphenomenon and con-
sequences ofits disturbance. Enhanced estrogen respon-
siveness ofthe cellsbycAMPelevationmaymeritexplo-
ration, especially in conjunction with alterations in the
growth substratum that have permitted maintenance of
normal function in cultured mammary and tracheal
epithelial cells (62,63). In addition, since the adenyl cy-
clase/phosphodiesterasepathwayissensitive toperturba-
tionby exogenousagents, the cellsmayprovide asuitable
model for examining certain types of reproductive tox-
icity.
As these results demonstrate, epithelial cell culture
models can be instrumental in elucidating physiological
andbiochemical basesfordifferences inregulation andre-
sponse amongtissue types and species. Further investi-
gations inthese directions, inconjunction with invivo ob-
servations, could ultimately aid in prediction of human
responses to new or uncharacterized toxic substances.
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